Sunitinib malate
- Level
- Commodity
- Parent
- 51112000
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51112017This classification denotes a tyrosine kinase inhibitor and angiogenesis activator inhibitor with the molecular formula C22H27FN4O2.C4H6O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier LVX8N1UT73. European Medicines Agency schedules sunitinib malate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB22366. The term sunitinib malate is a United States Adopted Name designation. As of Q4 2014, SUNITINIB MALATE remains US FDA's Preferred Term for this commodity. Sunitinib malate bears US NLM identifiers UMLS ID C1700685 and NCI Concept Code C26673. Most nations, for tariff and trade purposes, schedule sunitinib malate under HS 29337900 and SITC 51561. SMILES: CCN(CC)CCNC(=O)C1C(C([NH]C1C)/C=C\2/C3CC(CCC3NC2=O)F)C.C([C@@H](C(=O)O)O)C(=O)O.
Same parent
Under 51112000 · 37Activities that produce or sell this
KBLI · 8Inherited from family 51110000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.